APOTHEEK VANDEWYNCKEL financials
A multi-period view of the public annual-account figures reported for APOTHEEK VANDEWYNCKEL, with comparable measures and links to available source documents.
Company overviewRegistry number
0885816371
Fiscal coverage
2024–2025
Public sources
cbso_bulk
Data updated
Jul 29, 2026
Financial evidence
Latest movements for APOTHEEK VANDEWYNCKEL
2025 versus 2024
- Operating line
- €279,197
- EBITDA
- €178,771
- Total assets
- €673,298
- Equity
- €323,881
+11.6%
+17.9%
+16.3%
+2.4%
EBITDA margin +64% · Equity ratio +48.1%
Multi-year filings
Source: NBB/CBSOFiled annual accounts by fiscal year
Public regulator-filed figures across 2 years.
Fiscal year | Gross margin | EBITDA | Total assets | Equity | Filing |
|---|---|---|---|---|---|
| 202530 Sept 2025 | €279,197 | €178,771 | €673,298 | €323,881 | - |
| 202430 Sept 2024 | €250,192 | €151,572 | €578,929 | €316,249 | - |
Figures reproduce public filings and may use country-specific accounting definitions. They are not audited by Upswitch.